معرفی
Olli Lohi is a Professor of Pediatrics specializing in pediatric oncology, particularly focusing on acute lymphoblastic leukemia (ALL) and related genetic mechanisms. His work integrates molecular biology, epidemiology, and clinical research to advance understanding of leukemia pathogenesis and treatment resistance. He collaborates widely on studies involving nationwide population data, genomic analyses, and preclinical drug screening models.
Research interests include:
- Genetic drivers of pediatric ALL (e.g., ETV6-RUNX1 fusion genes)
- Epidemiological factors influencing leukemia incidence
- Chemotherapy response dynamics using single-cell technologies
- Post-pandemic shifts in pediatric autoimmune blood disorders
- Novel therapeutic targets via SUMOylation inhibition and glucocorticoid pathways
Recent work highlights:
- Nationwide studies on childhood leukemia clustering and CT radiation risks
- Zebrafish models for drug screening
- Single-cell profiling of chemotherapy-driven leukemic subpopulations
He has supervised doctoral candidates and served as a reviewer for scientific journals. His datasets include genomic profiles of pediatric ALL and epidemiological tumor registries.
۰مقاله منتشرشده
